This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.


Competition & State Aid

  • European Commission addresses State aid support in Communication on tackling nonperforming loans in the aftermath of COVID-19 pandemic
  • European Commission Executive Vice-President Margrethe Vestager speech on hydrogenrelated projects, including potential support by COVID-19 recovery funds
  • EU approves new and amended Member State measures to support the economy

Trade / Export Controls

  • European Parliament and EU Member States reach political agreement on new Customs Programme for 2021-2027
  • European Commission publishes second Counterfeit and Piracy Watch List

Medicines, Medical Devices, and Personal Protective Equipment

  • European Commission grants conditional marketing authorization for Pfizer/BioNTech COVID-19 vaccine
  • Moderna COVID-19 vaccine: European Commission purchases additional doses and EMA accelerates approval timeline
  • European Commission adopts a proposal for a Council Recommendation on use and validation of rapid COVID-19 tests

Cybersecurity, Privacy & Data Protection

  • European Medicines Agency pursues investigation of cyberattack

To view the full article, please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.